TRUE BEARING

Serial Number 90570604
734

Registration Progress

Application Filed
Mar 10, 2021
Under Examination
Jan 4, 2022
Approved for Publication
Nov 9, 2021
Published for Opposition
Nov 9, 2021
Registered

Trademark Image

TRUE BEARING

Basic Information

Serial Number
90570604
Filing Date
March 10, 2021
Published for Opposition
November 9, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Jun 25, 2024
Application
Pending
Classes
010 042 044

Rights Holder

True Bearing Diagnostics, Inc.

03
Address
2450 Virginia Avenue, NW, Suite # E117
Washington, DC 20037

Ownership History

True Bearing Diagnostics, Inc.

Original Applicant
03
Washington, DC

True Bearing Diagnostics, Inc.

Owner at Publication
03
Washington, DC

Legal Representation

Attorney
Ron N. Dreben

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

32 events
Date Code Type Description Documents
Jun 25, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 25, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Jun 25, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 20, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 18, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 18, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 30, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 28, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 28, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 28, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 4, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 2, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 2, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 2, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 5, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 2, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 2, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 2, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 1, 2022 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Jul 1, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 1, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 1, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 4, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 9, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 9, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 20, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 5, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 5, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 10, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 13, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Medical diagnostic blood testing apparatus for use in the field of coronary artery disease; Medical test kits in the field of coronary artery disease consisting primarily of a blood collection tube containing a preservative, a set of reagents for purifying RNA, a set of primers and probes for quantifying transcript levels, and related computer software featuring an algorithm for computing risk of coronary artery disease sold as a unit, for home use and for use by medical practitioners in the diagnosis of Atherosclerotic burden; medical devices for diagnosing coronary artery disease
Class 042
Research services in the field of medicine, namely, scientific research services and medical research
Class 044
Medical services, medical testing of blood, medical testing for diagnostic purposes, medical testing, namely, coronary artery disease (CAD) testing for diagnostic or treatment purposes, medical assessment services, namely, providing coronary and vascular risk assessment for diagnostic or treatment purposes, stroke risk assessment for diagnostic or treatment purposes, aneurysm risk assessment for diagnostic or treatment purposes, and peripheral vascular disease risk assessment for diagnostic or treatment purposes; providing medical advice, namely, providing Atherosclerotic load risk assessment guidance for hypercholesterolemia treatment purposes; medical testing in the nature of appendicitis testing by measuring RNA or protein levels in blood, pneumonia testing by measuring RNA or protein levels in blood, and biofilm testing by measuring RNA or protein levels in blood, all for diagnostic or treatment purposes; medical analysis for the treatment of coronary artery disease (CAD); healthcare

Classification

International Classes
010 042 044